RESEARCH AND PUBLICATIONS

  • Farhat, F. Co PI: HIV Stigma-A Survey Study

  • Farhat, F. Co PI: Does trait for sickle cell disease protect against HIV transmission and progression? :  A proof of concept study.

  • Farhat, F. Site Co Investigator for the following trials sponsored by NIH:

    • ACTG 5257: A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers

    • 1077 HS: HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival

    • A 5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females. 

    • P 1086: Co Investigator – A phase II study to assess the safety and immunogenicity of an inactivated swine origin H1N1 Influenza vaccine in HIV-1 infected pregnant women. 

    • ACTG 5241: Co Investigator - The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen.

    • ATN 061: Co Investigator – Preservation and expansion of T-cell subsets following HAART de intensification to Atazanavir/ritonavir in adolescents and young adults with CD4 + T cells >350 cells/mm3 initiating HAART. 

    • ATN 071: Co Investigator – Neurocognitive assessment in youth initiating HAART. 

  • Barron Y, Cole SR, Greenblatt RM, Cohen MH, Anastos K, DeHovitz JA, Delapenha R, and Gange SJ.  Effect of discontinuing antiretroviral therapy on survival of women initiated on HAART. AIDS 18:1579-1584, 2004.

  • Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, and Hoover DR.  Total Lymphocyte Count, Hemoglobin and Delayed-Type Hypersensitivity as Predictors of Death and AIDS Illness in HIV-1 Infected  Women  Receiving HAART. J Acquir Immune Defic Syndr 35;383-392, 2004.

  • Anastos K, Schneider M, Gange S, Minkoff H, Greenblatt R, Feldman J, Levine A, Delapenha R, and Cohen M.  The Association of Race, Sociodemographic, and Behavioral Characteristics With Response to HAART in Women.  J Acquir Immune Defic Syndr 39(5); 537-544, 2005.

  • Reddy R, Daftary  MN, Delapenha R, Dutta A, Oliver J, Frederick W. Avascular Necrosis and Protease Inhibitors. J. Nat. Med. Assoc.  97; 1-4, 2005.

  • Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y, Wylvon V, Bacon M, Minkoff  H,  Levine A, Cohen M, and Greenblatt R.  The association of serum ferritin and transferrin receptor concentration  with mortality in women with HIV infection. Haematologic (91) 6:739-743, 2006.

  • Jaeger J, Patel M, Dharan N, Hancock K, Meites E, Matson C, Gladden M, Sugerman D, Doshi S, Blau D, Harriman K, Whaley M, Sun H, et al. 2009 Pandemic Influenza A/H1N1 Virus Transmission Among Healthcare Personnel – Southern California, 2009. Infect Control Hosp Epidemiol 2011; 32 (12): 1149-57.

  • Doshi, S, Kamimoto L, Finelli L, et al. Description of Antiviral Treatment among Adults Hospitalized with Influenza Before and During the 2009 Pandemic – United States, 2005-09. J Infect Dis 2011; 204: 1848-56.

  • Fry AM, Hancock K, Patel M, Gladden M, Doshi S, Blau DM, Sugerman D, Beguilla B, Lu X, Noland H, et al for the influenza serology working group. The first cases of the 2009 pandemic influenza A (H1N1) virus infection in the United States: a serologic investigation demonstrating early transmission. Influenza and Other Resp Viruses 2012; 6 (3): e48-53.

  • Doshi S, Stauffer K, Fiebelkorn AP, Lafond K, Davidson H, Apostolou A, et al. The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall, 2009. Am J Epidemiol 2012; 176 (6): 519-26.

  • Doshi S, Fang Chen T, Zapata J, Holzman RS, Zapata LC, Aberg JA, Sivapalasingham S. Risk factors for tuberculin skin test conversion among HIV-infected patients in New York City. Int J Inf Dis 2012; 16 (7): e518-21.

  • Bryant, M. Principal Investigator for Ryan White Part A Grant

  • Bryant, M. Howard University Site Principal Investigator, DC Cohort study

  • Bryant, M. Howard University Site Principal Investigator, “Use of Venipuncture and Finger Stick Whole Blood for Comparative Flow Cytometry Evaluation”

  • Bryant, M. Resistance among Mycobacterial tuberculosis isolates

  • Bryant, M. Impact of Patient Navigation Services on adherence with appointments and medical care among HIV-positive patients

  • Ocular findings in human immunodeficiency virus patients in Washington, DC; KaleemMA, Ramsahai S, Del Fierro K, Rasul S, Onumah C, Lerebours V, Gajjala J, Copeland RA, Jones LS. IntOphthalmol. 2012 Apr;32(2):145-51. Epub 2012 Mar 27.

  • Graves' Disease as a Manifestation of Immune Reconstitution in HIV-Infected Individuals after Initiation of Highly Active Antiretroviral Therapy; Samad Rasul, Robert Delapenha, Faria Farhat, Jhansi Gajjala, and Syeda Mehreen Zahra; AIDS Research and Treatment, Volume 2011 (2011)

  • Lemierre’s syndrome resulting from streptococcal induced otitis media and mastoiditis: a case report; Che M Harris, Micean Johnikin, Hope Rhodes, Theresa Fuller, Sohail R Rana, Hasan Nabhani, Dulara Hussain, Mohan Kurukumbi, Annapurni Jayam-Trouth, Jhansi Gajjala, Faria Farhat and Vinod Mody ; Journal of medical case reports, 2009.

  • Daftary, M. Managing ARV drug interactions in an urban teaching institution

  • Daftary, M. Health Literacy in Relation to Medication Adherence in the HIV Population

  • Daftary, M. Mobile4Health: Text message‐aided adherence campaign designed for HIV patients of color in an urban setting

  • Daftary, M. Evaluating carbapenem resistance patterns in Pseudomonas aeruginosa isolates and associated risk factors in a tertiary care hospital in Washington DC

  • Daftary, M. An Analysis of HIV Diagnosis and Treatment Using the Medical Expenditure Panel Survey Data, 1996 – 1999